Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London W2 1NY, UK.
Int J Mol Sci. 2020 Oct 7;21(19):7394. doi: 10.3390/ijms21197394.
Aptamers are a novel technology enabling the continuous measurement of analytes in blood and other body compartments, without the need for repeated sampling and the associated reagent costs of traditional antibody-based methodologies. Aptamers are short single-stranded synthetic RNA or DNA that recognise and bind to specific targets. The conformational changes that can occur upon aptamer-ligand binding are transformed into chemical, fluorescent, colour changes and other readouts. Aptamers have been developed to detect and measure a variety of targets in vitro and in vivo. Gonadotropin-releasing hormone (GnRH) is a pulsatile hypothalamic hormone that is essential for normal fertility but difficult to measure in the peripheral circulation. However, pulsatile GnRH release results in pulsatile luteinizing hormone (LH) release from the pituitary gland. As such, LH pulsatility is the clinical gold standard method to determine GnRH pulsatility in humans. Aptamers have recently been shown to successfully bind to and measure GnRH and LH, and this review will focus on this specific area. However, due to the adaptability of aptamers, and their suitability for incorporation into portable devices, aptamer-based technology is likely to be used more widely in the future.
适体是一种新型技术,能够在无需重复采样和传统基于抗体方法所需的相关试剂成本的情况下,连续测量血液和其他体腔中的分析物。适体是短的单链合成 RNA 或 DNA,能够识别和结合特定的靶标。适体-配体结合时发生的构象变化被转化为化学、荧光、颜色变化和其他读出信号。适体已被开发用于检测和测量体外和体内的各种靶标。促性腺激素释放激素 (GnRH) 是一种脉冲式下丘脑激素,对正常生育至关重要,但在周围循环中难以测量。然而,脉冲 GnRH 释放导致垂体释放黄体生成素 (LH) 的脉冲式释放。因此,LH 脉冲性是确定人类 GnRH 脉冲性的临床金标准方法。最近已经证明适体能够成功结合并测量 GnRH 和 LH,本综述将重点关注这一特定领域。然而,由于适体的适应性及其适合整合到便携式设备中,基于适体的技术在未来可能会得到更广泛的应用。